|
1
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Cho KR, Chu C, Cohn D, Crispens MA, Dorigo O, et al:
Cervical Cancer, Version 2.2015. J Natl Compr Canc Netw.
13:395–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng R, Zeng H, Zhang S, Chen T and Chen
W: National estimates of cancer prevalence in China, 2011. Cancer
Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coulombe PA and Omary MB: ‘Hard’ and
‘soft’ principles defining the structure, function and regulation
of keratin intermediate filaments. Curr Opin Cell Biol. 14:110–122.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greystoke A, Dean E, Saunders MP, Cummings
J, Hughes A, Ranson M, Dive C and Renehan AG: Multi-level evidence
that circulating CK18 is a biomarker of tumour burden in colorectal
cancer. Br J Cancer. 107:1518–1524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schneider J: Tumor markers in detection of
lung cancer. Adv Clin Chem. 42:1–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hernandez BY, Frierson HF, Moskaluk CA, Li
YJ, Clegg L, Cote TR, McCusker ME, Hankey BF, Edwards BK and
Goodman MT: CK20 and CK7 protein expression in colorectal cancer:
Demonstration of the utility of a population-based tissue
microarray. Hum Pathol. 36:275–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moll R, Divo M and Langbein L: The human
keratins: Biology and pathology. Histochem Cell Biol. 129:705–733.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahn SK, Moon HG, Ko E, Kim HS, Shin HC,
Kim J, You JM, Han W and Noh DY: Preoperative serum tissue
polypeptide-specific antigen is a valuable prognostic marker in
breast cancer. Int J Cancer. 132:875–881. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Escobar-Hoyos LF, Shah R, Roa-Peña L,
Vanner EA, Najafian N, Banach A, Nielsen E, Al-Khalil R, Akalin A,
Talmage D and Shroyer KR: Keratin-17 promotes p27KIP1 nuclear
export and degradation and offers potential prognostic utility.
Cancer Res. 75:3650–3662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan HS, Jiang WH, He Y, Wang DS, Wu ZJ, Wu
DS, Gao L, Bao Y, Shi JZ, Liu B, et al: KRT8 upregulation promotes
tumor metastasis and is predictive of a poor prognosis in clear
cell renal cell carcinoma. Oncotarget. 8:76189–76203. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheung KJ, Padmanaban V, Silvestri V,
Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta
KJ, Bader JS and Ewald AJ: Polyclonal breast cancer metastases
arise from collective dissemination of keratin 14-expressing tumor
cell clusters. Proc Natl Acad Sci USA. 113:E854–E863. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu J: Nuclear Keratin 17 and its role in
the DNA Damage Response. Doctoral dissertation. Johns Hopkins
University. 2017.
|
|
13
|
Saha SK, Choi HY, Kim BW, Dayem AA, Yang
GM, Kim KS, Yin YF and Cho SG: KRT19 directly interacts with
β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling
pathway and breast cancer properties. Oncogene. 36:332–349. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bilici A: Cytokeratin 18 for chemotherapy
efficacy in gastric cancer. Transl Gastrointest Cancer. 4:200–206.
2015.
|
|
15
|
Zhang B, Wang J, Liu W, Yin Y, Qian D,
Zhang H, Shi B, Li C, Zhu J, Zhang L, et al: Cytokeratin 18
knockdown decreases cell migration and increases chemosensitivity
in non-small cell lung cancer. J Cancer Res Clin Oncol.
142:2479–2487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin B, Zhang M, Zeng Y, Li Y, Zhang C,
Getzenberg RH and Song Y: Downregulation of cytokeratin 18 is
associated with paclitaxel-resistance and tumor aggressiveness in
prostate cancer. Int J Oncol. 48:1730–1736. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang YL, Chen J, Yan W, Zang D, Qin Q and
Deng AM: Diagnostic accuracy of cytokeratin-19 fragment (CYFRA
21-1) for bladder cancer: A systematic review and meta-analysis.
Tumour Biol. 36:3137–3145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagel M, Schulz J, Maderer A, Goepfert K,
Gehrke N, Thomaidis T, Thuss-Patience PC, Al-Batran SE,
Hegewisch-Becker S, Grimminger P, et al: Cytokeratin-18 fragments
predict treatment response and overall survival in gastric cancer
in a randomized controlled trial. Tumor Biol.
40:1010428318764002018. View Article : Google Scholar
|
|
19
|
Sjöström J, Alfthan H, Joensuu H, Stenman
UH, Lundin J and Blomqvist C: Serum tumour markers CA 15-3, TPA,
TPS, hCGbeta and TATI in the monitoring of chemotherapy response in
metastatic breast cancer. Scand J Clin Lab Invest. 61:431–441.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yaman E, Coskun U, Sancak B, Buyukberber
S, Ozturk B and Benekli M: Serum M30 levels are associated with
survival in advanced gastric carcinoma patients. Int
Immunopharmacol. 10:719–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Demiray M, Ulukaya EE, Arslan M, Gokgoz S,
Saraydaroglu O, Ercan I, Evrensel T and Manavoglu O: Response to
neoadjuvant chemotherapy in breast cancer could be predictable by
measuring a novel serum apoptosis product, caspase-cleaved
cytokeratin 18: A prospective pilot study. Cancer Invest.
24:669–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ulukaya E, Yilmaztepe A, Akgoz S, Linder S
and Karadag M: The levels of caspase-cleaved cytokeratin 18 are
elevated in serum from patients with lung cancer and helpful to
predict the survival. Lung Cancer. 56:399–404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ozturk B, Coskun U, Sancak B, Yaman E,
Buyukberber S and Benekli M: Elevated serum levels of M30 and M65
in patients with locally advanced head and neck tumors. Int
Immunopharmacol. 9:645–648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Homberg M and Magin TM: Beyond
expectations: Novel insights into epidermal keratin function and
regulation. Int Rev Cell Mol Biol. 311:265–306. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weng YR, Cui Y and Fang JY: Biological
functions of cytokeratin 18 in cancer. Mol Cancer Res. 10:485–493.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Messai Y, Noman MZ, Derouiche A, Kourda N,
Akalay I, Hasmim M, Stasik I, Ben Jilani S, Chebil M, Caignard A,
et al: Cytokeratin 18 expression pattern correlates with renal cell
carcinoma progression: Relationship with Snail. Int J Oncol.
36:1145–1154. 2010.PubMed/NCBI
|
|
27
|
Sullivan BT, Cherry JA, Sakamoto H, Henkes
LE, Townson DH and Rueda BR: Cytokeratin 18 expression inhibits
cytokine-induced death of cervical cancer cells. Int J Gynecol
Cancer. 20:1474–1481. 2010.PubMed/NCBI
|
|
28
|
Bühler H and Schaller G: Transfection of
keratin 18 gene in human breast cancer cells causes induction of
adhesion proteins and dramatic regression of malignancy in vitro
and in vivo. Mol Cancer Res. 3:365–371. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meng Y, Wu Z, Yin X, Zhao Y, Chen M, Si Y,
Yang J, Fu X and Han W: Keratin 18 attenuates estrogen receptor
alpha-mediated signaling by sequestering LRP16 in cytoplasm. BMC
Cell Biol. 10:962009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Castello A, Fischer B, Eichelbaum K, Horos
R, Beckmann BM, Strein C, Davey NE, Humphreys DT, Preiss T,
Steinmetz LM, et al: Insights into RNA biology from an atlas of
mammalian mRNA-binding proteins. Cell. 149:1393–1406. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gerstberger S, Hafner M and Tuschl T: A
census of human RNA-binding proteins. Nat Rev Genet. 15:829–845.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Landry JJ, Pyl PT, Rausch T, Zichner T,
Tekkedil MM, Stütz AM, Jauch A, Aiyar RS, Pau G, Delhomme N, et al:
The genomic and transcriptomic landscape of a HeLa cell line. G3
(Bethesda). 3:1213–1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: Accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biol. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Robinson MD, McCarthy D and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res 39 (Web Server Issue). W316–W322. 2011.
View Article : Google Scholar
|
|
37
|
Xia H, Chen D, Wu Q, Wu G, Zhou Y, Zhang Y
and Zhang L: CELF1 preferentially binds to exon-intron boundary and
regulates alternative splicing in HeLa cells. Biochim Biophys Acta
Gene Regul Mech. 1860:911–921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karantza V: Keratins in health and cancer:
More than mere epithelial cell markers. Oncogene. 30:127–138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Toivola DM, Boor P, Alam C and Strnad P:
Keratins in health and disease. Curr Opin Cell Biol. 32:73–81.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Serasanambati MR and Chilakapati SR:
Function of nuclear factor Kappa B (NF-κB) in human diseases-a
review. South Indian J Biol Sci. 2:368–387. 2016. View Article : Google Scholar
|
|
42
|
Magné N, Toillon RA, Bottero V, Didelot C,
Houtte PV, Gérard JP and Peyron JF: NF-kappaB modulation and
ionizing radiation: Mechanisms and future directions for cancer
treatment. Cancer Lett. 231:158–168. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen X, Kandasamy K and Srivastava RK:
Differential roles of RelA (p65) and c-Rel subunits of nuclear
factor kappa B in tumor necrosis factor-related apoptosis-inducing
ligand signaling. Cancer Res. 63:1059–1066. 2003.PubMed/NCBI
|
|
44
|
Fortier AM, Asselin E and Cadrin M:
Keratin 8 and 18 loss in epithelial cancer cells increases
collective cell migration and cisplatin sensitivity through
claudin1 up-regulation. J Biol Chem. 288:11555–11571. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Trisdale SK, Schwab NM, Hou X, Davis JS
and Townson DH: Molecular manipulation of keratin 8/18 intermediate
filaments: modulators of FAS-mediated death signaling in human
ovarian granulosa tumor cells. J Ovarian Res. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ku NO, Soetikno RM and Omary MB: Keratin
mutation in transgenic mice predisposes to Fas but not TNF-induced
apoptosis and massive liver injury. Hepatology. 37:1006–1014. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cheng J, Zhou T, Liu C, Shapiro JP, Brauer
MJ, Kiefer MC, Barr PJ and Mountz JD: Protection from Fas-mediated
apoptosis by a soluble form of the Fas molecule. Science.
263:1759–1762. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu C, Cheng J and Mountz JD: Differential
expression of human Fas mRNA species upon peripheral blood
mononuclear cell activation. Biochem J. 310:957–963. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Papoff G, Cascino I, Eramo A, Starace G,
Lynch DH and Ruberti G: An N-terminal domain shared by Fas/Apo-1
(CD95) soluble variants prevents cell death in vitro. J Immunol.
156:4622–4630. 1996.PubMed/NCBI
|
|
50
|
Tejedor JR, Papasaikas P and Valcárcel J:
Genome-wide identification of Fas/CD95 alternative splicing
regulators reveals links with iron homeostasis. Mol Cell. 57:23–38.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Stegh AH, Herrmann H, Lampel S,
Weisenberger D, Andrä K, Seper M, Wiche G, Krammer PH and Peter ME:
Identification of the cytolinker plectin as a major early in vivo
substrate for caspase 8 during CD95- and tumor necrosis factor
receptor-mediated apoptosis. Mol Cell Biol. 20:5665–5679. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lai YC, Cheng CC, Lai YS and Liu YH:
Cytokeratin 18-associated histone 3 modulation in hepatocellular
carcinoma: A mini review. Cancer Genomics Proteomics. 14:219–223.
2017. View Article : Google Scholar : PubMed/NCBI
|
